Application of GLP-1 Receptor Agonists in Cardiorenometabolic Syndrome. CARDIOLOGY OF UZBEKISTAN, [S. l.], v. 3, n. 1, p. 101–108, 2026. DOI: 10.70626/cardiouz-2026-3-00082. Disponível em: https://cardiojournal.uz/index.php/journal/article/view/145. Acesso em: 15 aug. 2026.